Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Nahid Shahabadi, Sara Amiri & Avat (Arman) Taherpour. (2019) Human serum albumin binding studies of a new platinum(IV) complex containing the drug pregabalin: experimental and computational methods. Journal of Coordination Chemistry 72:4, pages 600-618.
Read now
Read now
Yuki Mochida, Horacio Cabral & Kazunori Kataoka. (2017) Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opinion on Drug Delivery 14:12, pages 1423-1438.
Read now
Read now
Umar Ndagi, Ndumiso Mhlongo & Mahmoud E Soliman. (2017) Metal complexes in cancer therapy – an update from drug design perspective. Drug Design, Development and Therapy 11, pages 599-616.
Read now
Read now
Amit K. Jain & Sanyog Jain. (2016) Advances in oral delivery of anti-cancer prodrugs. Expert Opinion on Drug Delivery 13:12, pages 1759-1775.
Read now
Read now
Sara Zalba & María J Garrido. (2013) Liposomes, a promising strategy for clinical application of platinum derivatives. Expert Opinion on Drug Delivery 10:6, pages 829-844.
Read now
Read now
Ulrike Olszewski, Ernst Ulsperger, Klaus Geissler & Gerhard Hamilton. (2011) Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells. Journal of Experimental Pharmacology 3, pages 43-50.
Read now
Read now
Articles from other publishers (93)
Hui‐Xiang Tian, Jie Mei, Lei Cao, Jianan Song, Dingchao Rong, Man Fang, Zhe Xu, Juan Chen, Jie Tang, Haihua Xiao, Zhaoqian Liu, Peng‐Yuan Wang, Ji‐Ye Yin & Xiang‐Ping Li. (2023) Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer. Small 19:49.
Crossref
Crossref
Javier E. López‐Hernández, Nazia Nayeem, José P. Cerón‐Carrasco, Afruja Ahad, Aiman Hafeez, Ignacio E. León & Maria Contel. (2023) Platinum(IV)–Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple‐Negative Breast Cancer Models. Chemistry – A European Journal 29:59.
Crossref
Crossref
Anna Farasat, Luca Labella, Maria Luisa Di Paolo, Lisa Dalla Via & Simona Samaritani. (2023) Dibromo- and Dichlorotriphenylphosphino N-Acyclic Carbene Complexes of Platinum(II)—Synthesis and Cytotoxicity. Inorganics 11:9, pages 365.
Crossref
Crossref
Shunzhe Zheng, Guanting Li, Jianbin Shi, Xinying Liu, Meng Li, Zhonggui He, Chutong Tian & Ken-ichiro Kamei. (2023) Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release 361, pages 819-846.
Crossref
Crossref
Yunxia Yang, Pengge Wang, Zengrui Ji, Xi Xu, Hongmei Zhang & Yanqing Wang. (2023) Polysaccharide‑platinum complexes for cancer theranostics. Carbohydrate Polymers 315, pages 120997.
Crossref
Crossref
Rishabha Malviya, Arun Kumar Singh & Deepika YadavRishabha Malviya, Arun Kumar Singh & Deepika Yadav. 2023. Multi‐Drug Resistance in Cancer. Multi‐Drug Resistance in Cancer
155
170
.
Wei Liu, Chuyi Yu, Miaomiao Wang, Youyou He, Zhongjie Guo, Jin He, Ru Jiang, Qin Xu, Jianming Liang & Shengzheng Wang. (2023)
Discovery of Platinum
IV
–Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents
. Journal of Medicinal Chemistry 66:12, pages 8066-8085.
Crossref
Crossref
YouRu Wu, LiXia Hou, JianFeng Lan, Feng Yang, GuoJin Huang, Wei Liu & Yi Gou. (2023) Mixed-ligand copper(II) hydrazone complexes: Synthesis, structure, and anti-lung cancer properties. Journal of Molecular Structure 1279, pages 134986.
Crossref
Crossref
Angelico D. Aputen, Maria George Elias, Jayne Gilbert, Jennette A. Sakoff, Christopher P. Gordon, Kieran F. Scott & Janice R. Aldrich-Wright. (2023) Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents. Cancers 15:9, pages 2460.
Crossref
Crossref
Qiyuan Zhou, Shu Chen, Zoufeng Xu, Gongyuan Liu, Shuyuan Zhang, Zhigang Wang, Man‐Kit Tse, Shek‐Man Yiu & Guangyu Zhu. (2023) Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups. Angewandte Chemie International Edition 62:18.
Crossref
Crossref
Qiyuan Zhou, Shu Chen, Zoufeng Xu, Gongyuan Liu, Shuyuan Zhang, Zhigang Wang, Man‐Kit Tse, Shek‐Man Yiu & Guangyu Zhu. (2023) Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups. Angewandte Chemie 135:18.
Crossref
Crossref
Carlo Marotta, Ester Giorgi, Francesca Binacchi, Damiano Cirri, Chiara Gabbiani & Alessandro Pratesi. (2023) An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies. Inorganica Chimica Acta 548, pages 121388.
Crossref
Crossref
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Prateek Pathak, Maria Grishina, Jagat Pal Yadav, Amita Verma & Pradeep Kumar. (2023) Metal Complexes in Cancer Treatment: Journey So Far. Chemistry & Biodiversity 20:4.
Crossref
Crossref
Eoin Moynihan, Silvia Panseri, Giada Bassi, Arianna Rossi, Elisabetta Campodoni, Eithne Dempsey, Monica Montesi, Trinidad Velasco-Torrijos & Diego Montagner. (2023) Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma. International Journal of Molecular Sciences 24:7, pages 6028.
Crossref
Crossref
Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K. Keppler, Christian R. Kowol, Dan Gibson, Michael Grusch, Walter Berger & Petra Heffeter. (2023) Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. Pharmaceutics 15:2, pages 677.
Crossref
Crossref
Tanzimjahan A. Saiyed, Jerry O. Adeyemi, Gbemisola M. Saibu, Moganavelli Singh, Adebola O. Oyedeji, Eric C. Hosten & Damian C. Onwudiwe. (2023) Bipyridine adducts of Zn(II) and Ni(II) bis (N-methyl-N-phenyl dithiocarbamate): Synthesis, characterization, and biological applications. Journal of Molecular Structure 1274, pages 134335.
Crossref
Crossref
Ranjit Singh, Anjleena Malhotra & Ranju Bansal. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
499
537
.
Garima Sharma, Monika Kadian, Priya Joon & Anil Kumar. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences
1
12
.
Quan-Bing Chen, Ling-Yue Zhou, Ling-Xin Shi, Yang Cheng, Kui Wu, Qiong Yuan, Zhi-Jun Dong, Hua-Zhi Gu, Xian-Zheng Zhang & Tao Zou. (2022) Platinum(IV) Complex-Loaded nanoparticles with photosensitive activity for cancer therapy. Coordination Chemistry Reviews 472, pages 214789.
Crossref
Crossref
Amit Kumar Pradhan, Abhijit Shyam, Abhijit Dutta & Paritosh Mondal. (2022) Quantum Chemical Investigation on Hydrolysis of Orally Active Organometallic Ruthenium(II) and Osmium(II) Anticancer Drugs and Their Interaction with Histidine. The Journal of Physical Chemistry B 126:46, pages 9516-9527.
Crossref
Crossref
Angelico D. Aputen, Maria George Elias, Jayne Gilbert, Jennette A. Sakoff, Christopher P. Gordon, Kieran F. Scott & Janice R. Aldrich-Wright. (2022) Potent Chlorambucil-Platinum(IV) Prodrugs. International Journal of Molecular Sciences 23:18, pages 10471.
Crossref
Crossref
Sabyasachi Banerjee & Subhasis Banerjee. (2022) Metal-based Complexes as Potential Anti-cancer Agents. Anti-Cancer Agents in Medicinal Chemistry 22:15, pages 2684-2707.
Crossref
Crossref
Shoohb Alassadi, Michelle J. Pisani & Nial J. Wheate. (2022) A chemical perspective on the clinical use of platinum-based anticancer drugs. Dalton Transactions 51:29, pages 10835-10846.
Crossref
Crossref
Danka Obreshkova, Stefka Ivanova & Pavlina Yordanova-Laleva. (2022) Influence of chemical structure and mechanism of hydrolysis on pharmacological activity and toxicological profile of approved platinum drugs. Pharmacia 69:3, pages 645-653.
Crossref
Crossref
Mohamed M. El-bendary, Tamer S. Saleh, Mansour M. Alomari, Ehab M. M. Ali, Bambar Davaasuren, Mariusz Jaremko & Bandar A. Babgi. (2022) Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex. Molecules 27:14, pages 4406.
Crossref
Crossref
Lihua Chen, Pan Zhao, Jing Yang, Xiali Liao, Bo Yang & Chuanzhu Gao. (2022) Synthesis, characterization, and antitumor biological evaluation of novel fluorine‐containing platinum (IV) complexes. Applied Organometallic Chemistry 36:7.
Crossref
Crossref
Marco Zuccolo, Noemi Arrighetti, Paola Perego & Diego Colombo. (2022) Recent Progresses in Conjugation with Bioactive Ligands to Improve
the Anticancer Activity of Platinum Compounds. Current Medicinal Chemistry 29:15, pages 2566-2601.
Crossref
Crossref
Loredana G. Marcu. (2022) Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds. Pharmaceuticals 15:2, pages 255.
Crossref
Crossref
Stefka Ivanova. (2022) Comparative assessment of clinical trials, indications, pharmacokinetic parameters and side effects of approved platinum drugs. Pharmacia 69:1, pages 1-7.
Crossref
Crossref
Kun Peng, Bing-Bing Liang, Wenting Liu & Zong-Wan Mao. (2021) What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives. Coordination Chemistry Reviews 449, pages 214210.
Crossref
Crossref
Sema Caglar, Ahmet Altay, Mehmet Kuzucu & Bulent Caglar. (2021) In Vitro Anticancer Activity of Novel Co(II) and Ni(II) Complexes of Non-steroidal Anti-inflammatory Drug Niflumic Acid Against Human Breast Adenocarcinoma MCF-7 Cells. Cell Biochemistry and Biophysics 79:4, pages 729-746.
Crossref
Crossref
Kuan-Ju Chen, Adam J. Plaunt, Franziska G. Leifer, Jeong Yeon Kang & David Cipolla. (2021) Recent advances in prodrug-based nanoparticle therapeutics. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 219-243.
Crossref
Crossref
Dan Gibson. (2021) Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men. ChemMedChem 16:14, pages 2188-2191.
Crossref
Crossref
Dan Gibson. (2021) Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?. Journal of Inorganic Biochemistry 217, pages 111353.
Crossref
Crossref
Tasha R. Steel, Kelvin K.H. Tong, Tilo Söhnel, Stephen M.F. Jamieson, L. James Wright, James D. Crowley, Muhammad Hanif & Christian G. Hartinger. (2021) Homodinuclear organometallics of ditopic N,N-chelates: Synthesis, reactivity and in vitro anticancer activity. Inorganica Chimica Acta 518, pages 120220.
Crossref
Crossref
Henryk Mastalarz, Agnieszka Mastalarz, Joanna Wietrzyk, Magdalena Milczarek, Andrzej Kochel & Andrzej Regiec. (2020) Synthesis of Platinum(II) Complexes with Some 1-Methylnitropyrazoles and In Vitro Research on Their Cytotoxic Activity. Pharmaceuticals 13:12, pages 433.
Crossref
Crossref
Mehdi Khalaj, Abolfazl Olyaei, Mahdieh Sadeghpour, Arash Lalegani, Janusz Lipkowski & Alan J. Lough. (2020)
Platinum(II) complex with 4-nitro-
N
-(pyridin-2-ylmethylidene)aniline: synthesis, characterization, crystal structure and antioxidant activity
. Acta Crystallographica Section C Structural Chemistry 76:11, pages 1005-1009.
Crossref
Crossref
Peter A. Ajibade, Fartisincha P. Andrew, Nandipha L. Botha & Nolwazi Solomane. (2020) Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes. Molecules 25:16, pages 3584.
Crossref
Crossref
Chunyan Jia, Yanwei Cong, Shaoping Pu, Linxiang Cai, Yunshuang Zhong, Xinzhong Zhang, Xiali Liao, Yamin Li, Bo Yang & Chuanzhu Gao. (2020) Synthesis, characterization, and biological activity of new mixed ammine/amine platinum(IV) complexes. Applied Organometallic Chemistry 34:8.
Crossref
Crossref
Zhikun Liu, Meng Wang, Hengshan Wang, Lei Fang & Shaohua Gou. (2020) Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance. European Journal of Medicinal Chemistry 194, pages 112269.
Crossref
Crossref
Ling Nie, Tiantian Niu, Jingjing Sun, Fugang Shen, Shuying Huo & Shigang Shen. (2020) Hydrogen halide assisted formation of peptide disulfides by a platinum(IV) complex oxidation in aqueous medium, a mechanistic study. Journal of Molecular Liquids 299, pages 112105.
Crossref
Crossref
Stéphane Bellemin‐Laponnaz. (2019) N‐Heterocyclic Carbene Platinum Complexes: A Big Step Forward for Effective Antitumor Compounds. European Journal of Inorganic Chemistry 2020:1, pages 10-20.
Crossref
Crossref
Ana M.F. Phillips & Armando J.L. Pombeiro. (2020) Transition Metal-Based Prodrugs for Anticancer Drug Delivery. Current Medicinal Chemistry 26:41, pages 7476-7519.
Crossref
Crossref
Eszter Boros, Paul J. Dyson & Gilles Gasser. (2020) Classification of Metal-Based Drugs according to Their Mechanisms of Action. Chem 6:1, pages 41-60.
Crossref
Crossref
Shuren Zhang, Xiaoyong Wang & Zijian Guo. 2020. Medicinal Chemistry. Medicinal Chemistry
149
182
.
Yao Zhao, Yankang Yang, Fengmin Xu, Wei Zheng, Qun Luo, Yanyan Zhang, Feifei Jia & Fuyi Wang. 2020. Medicinal Chemistry. Medicinal Chemistry
257
285
.
Mirela-Femanda Zaltariov, Maria Butnaru & Dragos Peptanariu. (2019) Cytotoxicity Evaluation of New Ruthenium Complexes. Cytotoxicity Evaluation of New Ruthenium Complexes.
Sumit Ghosh. (2019) Cisplatin: The first metal based anticancer drug. Bioorganic Chemistry 88, pages 102925.
Crossref
Crossref
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey & Domenico Osella. (2019) A view on multi-action Pt(IV) antitumor prodrugs. Inorganica Chimica Acta 492, pages 32-47.
Crossref
Crossref
Selin Hizal, Michaela Hejl, Michael A. Jakupec, Mathea S. Galanski & Bernhard K. Keppler. (2019) Synthesis, characterization, lipophilicity and cytotoxic properties of novel bis(carboxylato)oxalatobis(1-propylamine)platinum(IV) complexes. Inorganica Chimica Acta 491, pages 76-83.
Crossref
Crossref
Cai Li, Tianzhong Li, Linfeng Huang, Mengsu Yang & Guangyu Zhu. (2019) Self‐assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer. Chemistry – An Asian Journal 14:9, pages 1570-1576.
Crossref
Crossref
Dan Gibson. (2019) Multi-action Pt(IV) anticancer agents; do we understand how they work?. Journal of Inorganic Biochemistry 191, pages 77-84.
Crossref
Crossref
Xiaohui Wang, Xiaoyong Wang, Suxing Jin, Nafees Muhammad & Zijian Guo. (2018) Stimuli-Responsive Therapeutic Metallodrugs. Chemical Reviews 119:2, pages 1138-1192.
Crossref
Crossref
Qingpeng Wang, Xiaoxiao Tan, Zhifang Liu, Guoshuai Li, Ruiyan Zhang, Jinjian Wei, Shiben Wang, Dacheng Li, Bingquan Wang & Jun Han. (2018) Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism. European Journal of Pharmaceutical Sciences 124, pages 127-136.
Crossref
Crossref
Ahmet Altay, Sema Caglar, Bulent Caglar & Onur Sahin. (2018) Synthesis, structural, thermal elucidation and in vitro anticancer activity of novel silver(I) complexes with non-steroidal anti-inflammatory drugs diclofenac and mefenamic acid including picoline derivatives. Polyhedron 151, pages 160-170.
Crossref
Crossref
Georgi Momekov, Iva Ugrinova, Evdokia Pasheva, Daniela Tsekova & Galina Gencheva. (2018) Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts. International Journal of Molecular Sciences 19:8, pages 2451.
Crossref
Crossref
Filip Šebesta & Jaroslav V. Burda. (2018)
Interactions of Ascorbic Acid with Satraplatin and its
trans
Analog JM576: DFT Computational Study
. European Journal of Inorganic Chemistry 2018:13, pages 1481-1491.
Crossref
Crossref
Filip Šebesta, Katarína Baxová & Jaroslav V. Burda. (2018) Redox Potentials for Tetraplatin, Satraplatin, Its Derivatives, and Ascorbic Acid: A Computational Study. Inorganic Chemistry 57:3, pages 951-962.
Crossref
Crossref
Rita Nader, Joelle El Amm & JeannyB Aragon-Ching. (2018) Role of chemotherapy in prostate cancer. Asian Journal of Andrology 20:3, pages 221.
Crossref
Crossref
Fortuna Ponte, Ida Ritacco, Gloria Mazzone, Nino Russo & Emilia Sicilia. (2018) Theoretical determination of the aquation reaction mechanism of cyclometalated benzimidazole Ru(II) and Ir(III) anticancer complexes. Inorganica Chimica Acta 470, pages 325-330.
Crossref
Crossref
Daniel Yuan Qiang WongDaniel Yuan Qiang Wong. 2018. Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches. Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches
131
145
.
Serenella Medici, Massimiliano Francesco Peana & Maria Antonietta Zoroddu. 2018. Biomedical Applications of Metals. Biomedical Applications of Metals
3
48
.
Dorian M. Cheff & Matthew D. Hall. (2017) A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research. Journal of Medicinal Chemistry 60:11, pages 4517-4532.
Crossref
Crossref
Ida Ritacco, Merriam Al Assy, Mohamed K. Abd El-Rahman, Sherif Ashraf Fahmy, Nino Russo, Tamer Shoeib & Emilia Sicilia. (2017) Hydrolysis in Acidic Environment and Degradation of Satraplatin: A Joint Experimental and Theoretical Investigation. Inorganic Chemistry 56:10, pages 6013-6026.
Crossref
Crossref
Xi Hu, Fangyuan Li, Nabila Noor & Daishun Ling. (2017) Platinum drugs: from Pt(II) compounds, Pt(IV) prodrugs, to Pt nanocrystals/nanoclusters. Science Bulletin 62:8, pages 589-596.
Crossref
Crossref
R. F. Mulagaleev, D. Y. Leshok, A. K. Starkov, A. N. Matsulev & S. D. Kirik. (2017)
Multivariant Crystallization of Tetraplatin Precursors from Solutions Containing 1,2-C
6
H
10
(NH
3
)
2
?
2+
and [PtCl
6
]
2?
Ions
. Journal of Chemistry 2017, pages 1-12.
Crossref
Crossref
Einav Ratzon, Yousef Najajreh, Rami Salem, Hazem Khamaisie, Martin Ruthardt & Jamal Mahajna. (2016) Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study. BMC Cancer 16:1.
Crossref
Crossref
Kaitlin A. Doucette, Kelly N. Hassell & Debbie C. Crans. (2016) Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs. Journal of Inorganic Biochemistry 165, pages 56-70.
Crossref
Crossref
Timothy C. Johnstone, Kogularamanan Suntharalingam & Stephen J. Lippard. (2016) The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chemical Reviews 116:5, pages 3436-3486.
Crossref
Crossref
Ida Ritacco, Gloria Mazzone, Nino Russo & Emilia Sicilia. (2016) Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs. Inorganic Chemistry 55:4, pages 1580-1586.
Crossref
Crossref
Jing Ma, Qingpeng Wang, Xiande Yang, Wenpei Hao, Zhonglv Huang, Jiabao Zhang, Xin Wang & Peng George Wang. (2016)
Glycosylated platinum(
iv
) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
. Dalton Transactions 45:29, pages 11830-11838.
Crossref
Crossref
Ulka Vaishampayan, Daniel Shevrin, Mark Stein, Lance Heilbrun, Susan Land, Karri Stark, Jing Li, Brenda Dickow, Elisabeth Heath, Daryn Smith & Joseph Fontana. (2015) Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study. Urology 86:6, pages 1206-1211.
Crossref
Crossref
Xiaopeng Han, Jin Sun, Yongjun Wang & Zhonggui He. (2015) Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy. Medicinal Research Reviews 35:6, pages 1268-1299.
Crossref
Crossref
Daniel Yuan Qiang Wong, Wendy Wei Fang Ong & Wee Han Ang. (2015) Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes. Angewandte Chemie International Edition 54:22, pages 6483-6487.
Crossref
Crossref
Daniel Yuan Qiang Wong, Wendy Wei Fang Ong & Wee Han Ang. (2015) Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes. Angewandte Chemie 127:22, pages 6583-6587.
Crossref
Crossref
Federica Trudu, Filippo Amato, Petr Vaňhara, Tiziana Pivetta, E.M. Peña-Méndez & Josef Havel. (2015) Coordination compounds in cancer: Past, present and perspectives. Journal of Applied Biomedicine 13:2, pages 79-103.
Crossref
Crossref
Ezequiel Wexselblatt, Raji Raveendran, Sawsan Salameh, Aviva Friedman‐Ezra, Eylon Yavin & Dan Gibson. (2014)
On the Stability of Pt
IV
Pro‐Drugs with Haloacetato Ligands in the Axial Positions
. Chemistry – A European Journal 21:7, pages 3108-3114.
Crossref
Crossref
Irene Giang, Erin L. Boland & Gregory M. K. Poon. (2014) Prodrug Applications for Targeted Cancer Therapy. The AAPS Journal 16:5, pages 899-913.
Crossref
Crossref
Anosheh Afghahi & Melinda L Telli. (2014) The role of platinum therapy in triple-negative breast cancer. Breast Cancer Management 3:4, pages 377-385.
Crossref
Crossref
Elisabetta Gabano, Mauro Ravera & Domenico Osella. (2014) Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one. Dalton Transactions 43:26, pages 9813.
Crossref
Crossref
Ulka N. Vaishampayan, Joseph Fontana, Lance K. Heilbrun, Daryn Smith, Elisabeth Heath, Brenda Dickow & William D. Figg. (2014) Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer. Urologic Oncology: Seminars and Original Investigations 32:1, pages 31.e25-31.e33.
Crossref
Crossref
Isolda Romero-CanelónPeter J. Sadler. (2013) Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation. Inorganic Chemistry 52:21, pages 12276-12291.
Crossref
Crossref
M. P. M. Marques. (2013) Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor. ISRN Spectroscopy 2013, pages 1-29.
Crossref
Crossref
Alexander V. LyubimovBente Gammelgaard, Stefan Stürup & Charlotte Møller. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
25
.
Susan E. Bates, Laleh Amiri-Kordestani & Giuseppe Giaccone. (2012) Drug Development: Portals of Discovery. Clinical Cancer Research 18:1, pages 23-32.
Crossref
Crossref
Djordje Miljković, Jelena M. Poljarević, Filip Petković, Jana Blaževski, Miljana Momčilović, Ivana Nikolić, Tamara Saksida, Stanislava Stošić-Grujičić, Sanja Grgurić-Šipka & Tibor J. Sabo. (2012) Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N′-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects. European Journal of Medicinal Chemistry 47, pages 194-201.
Crossref
Crossref
C. Monneret. (2011) Platinum anticancer drugs. From serendipity to rational design. Annales Pharmaceutiques Françaises 69:6, pages 286-295.
Crossref
Crossref
Daniela Masciocchi, Arianna Gelain, Stefania Villa, Fiorella Meneghetti & Daniela Barlocco. (2011) Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy. Future Medicinal Chemistry 3:5, pages 567-597.
Crossref
Crossref
Shanta Dhar & Stephen J. Lippard. 2011. Bioinorganic Medicinal Chemistry. Bioinorganic Medicinal Chemistry
79
95
.
Hana Kostrhunova, Jana Kasparkova, Dan Gibson & Viktor Brabec. (2010) Studies on Cellular Accumulation of Satraplatin and Its Major Metabolite JM118 and Their Interactions with Glutathione. Molecular Pharmaceutics 7:6, pages 2093-2102.
Crossref
Crossref
Sonia M. Seng, Che-Kai Tsao, Matthew D. Galsky & William K. Oh. (2010) Cytotoxic chemotherapy for castration resistant prostate cancer: 2010 and beyond. Drug Discovery Today: Therapeutic Strategies 7:1-2, pages 17-22.
Crossref
Crossref
Hai-peng Yu, Zhi Guo, Wen-ge Xing, Xiu-ying Guo, Fang Liu & Hong Ni. (2010) Selective internal iliac artery oxaliplatin infusion: Another facultative treatment to unremitting hematuria in stage T4 bladder carcinoma. Clinical Oncology and Cancer Research 7:1, pages 55-59.
Crossref
Crossref
Mohamed El-bendary, Tamer S. Saleh, Mansour Alomari, Ehab Ali, Bambar Davaasuren, Bandar Babgi & Mariusz Jaremko Jaremko. (2022) Synthesis, Characterization and Crystal Structure of Platinum(IV) Complex as a Potent Anticancer Agent and an Efficient Catalyst. SSRN Electronic Journal.
Crossref
Crossref